Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Janet L. Andres is active.

Publication


Featured researches published by Janet L. Andres.


Cell | 1991

Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system

Fernando López-Casillas; Sela Cheifetz; Jacqueline Doody; Janet L. Andres; William S. Lane; Joan Massagué

We describe the primary structure of rat betaglycan, a polymorphic membrane-anchored proteoglycan with high affinity for transforming growth factor-beta (TGF-beta). As deduced from its cDNA sequence, the 853 amino acid core protein of betaglycan has an extracellular domain with clustered sites for potential attachment of glycosaminoglycan chains. These chains are dispensable for TGF-beta binding to the core protein. The transmembrane region and the short cytoplasmic tail of betaglycan are very similar to these regions in human endoglin, an endothelial cell membrane glycoprotein involved in intercellular recognition. The ectodomain of betaglycan can be released as a soluble proteoglycan; a potential cleavage site near the transmembrane region is identical to the highly regulated cleavage site of the membrane-anchored transforming growth factor-alpha precursor. The unique features of betaglycan suggest important roles in cell interaction with TGF-beta.


Journal of Cell Science | 1990

Transforming growth factor-β receptors and binding proteoglycans

Frederick T. Boyd; Sela Cheifetz; Janet L. Andres; Marikki Laiho; Joan Massagué

Summary Transforming growth factors-beta (TGFs-β) are representative of a superfamily whose members were first identified as regulators of morphogenesis and differentiation, and subsequently found to be structurally related. Other members of the family include the activins and inhibins, BMPs, MIS, the DPP-C gene product and Vg-1. When assayed by affinity-labelling techniques, TGFs-β bind to three distinct cell surface proteins which are present on most cells. These proteins are all of relatively low abundance but bind TGFs-β with affinities consistent with the biological potency of the factors. The Type I and Type II binding proteins are glycoproteins with estimated molecular weights of 53 and 73×103Mr, respectively. They both bind TGF-β1 significantly better than TGF-β2. The Type I receptor has been identified as the receptor which mediates many of the responses of TGFs-β, based on somatic cell genetic studies of epithelial cell mutants unresponsive to TGFs-β. Betaglycan is the third binding protein present on many, but not all, cell types and is a large proteoglycan (∼280×103Mr) with 100–120×103Mr, core proteins. A soluble form of this molecule is present in conditioned media of many cell lines and may be derived from the cell surface-associated molecule by cleavage of a small membrane anchor. Betaglycan binds TGF-β1 and TGF-β2 with similar affinity and this binding is to the core proteins, not the glycosaminoglycan side chains. This molecule may have a function in the localization and delivery or the clearance of activated TGFs-β. The molecular basis of TGF-β signalling is still largely unknown, but it is possible that one or more of these cell surface molecules signals via a novel mechanism, as the TGFs-β are biologically quite distinct from other factors that act via well-characterized signalling systems.


Journal of Cell Biology | 1994

Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites.

F López-Casillas; Hm Payne; Janet L. Andres; Joan Massagué


Journal of Cell Biology | 1989

Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta.

Janet L. Andres; K Stanley; Sela Cheifetz; Joan Massagué


Annals of the New York Academy of Sciences | 1990

TGF-β receptors and TGF-β binding proteoglycans : recent progress in identifying their functional properties

Joan Massagué; Sela Cheifetz; Frederick T. Boyd; Janet L. Andres


Journal of Biological Chemistry | 1988

The transforming growth factor-beta receptor type III is a membrane proteoglycan. Domain structure of the receptor.

Sela Cheifetz; Janet L. Andres; Joan Massagué


Journal of Biological Chemistry | 1992

Binding of two growth factor families to separate domains of the proteoglycan betaglycan.

Janet L. Andres; DeFalcis D; Masaki Noda; Joan Massagué


Molecular Reproduction and Development | 1992

TGF-β receptors

Joan Massagué; Janet L. Andres; Liliana Attisano; Sela Cheifetz; Fernando López-Casillas; Masahiko Ohtsuki; Jeffrey L. Wrana


Molecular Reproduction and Development | 1992

TGF-beta receptors.

Joan Massagué; Janet L. Andres; Liliana Attisano; Sela Cheifetz; Fernando López-Casillas; Masahiko Ohtsuki; Jeffrey L. Wrana


Journal of Biological Chemistry | 1991

Purification of the transforming growth factor-beta (TGF-beta) binding proteoglycan betaglycan

Janet L. Andres; Lars Rönnstrand; Sela Cheifetz; Joan Massagué

Collaboration


Dive into the Janet L. Andres's collaboration.

Top Co-Authors

Avatar

Joan Massagué

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Sela Cheifetz

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Fernando López-Casillas

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Masahiko Ohtsuki

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Frederick T. Boyd

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masaki Noda

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Jacqueline Doody

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

K Stanley

Memorial Sloan Kettering Cancer Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge